---

Market Overview

---

The global market for minimally invasive spine technologies exhibited a value of $3,181 million in 2022, with expectations to reach $9,407 million by 2032. This represents a compound annual growth rate (CAGR) of 11.45% during the forecast period of 2022 to 2032. The growth in this market can be attributed to the increasing preference for minimally invasive spine surgical procedures on a global scale, as well as the growing awareness among practitioners regarding simulation, training, and continuous medical education.

Minimally invasive spine surgery (MISS) has gained significant popularity in recent years due to advancements in surgical techniques and technologies. The primary objective of MISS is to minimize surgical-related injuries and preserve normal anatomy while achieving comparable surgical outcomes to traditional open procedures. Consequently, patients who undergo MISS often experience fewer adverse effects during and after surgery, shorter surgical times, and quicker returns to work, leading to improved quality of life. The continuous technological advancements in surgical systems and instruments have brought about groundbreaking changes in the healthcare landscape worldwide. Minimally invasive spine technology has successfully permeated various surgical fields. The evolution of technologies, coupled with advancements in computing, has enhanced surgeons’ skills, resulting in higher accuracy in complex surgical procedures. Additionally, the market has witnessed increased competition among key players in terms of patents.

However, the demand for minimally invasive spine technologies faced a decline during the pandemic due to the postponement of elective surgeries and non-urgent procedures. The closure of elective surgery and outpatient clinics resulted in a reduction in spinal surgeons’ workload. Nevertheless, it was crucial to provide emergency spinal care throughout the pandemic, including the development of guidelines to facilitate proper patient handling by spinal surgeons.

Moreover, the implementation of lockdowns and travel restrictions during the pandemic led to delays in procuring raw materials and delivering them to end users.

The following factors drive the demand for minimally invasive spine technologies:
Increasing incidences and prevalence of spinal disorders.
Rising preference for minimally invasive spine surgeries.
Technological advancements in minimally invasive spine surgical procedures.

However, the market is expected to face certain limitations due to the following challenges:
Lack of a well-established landscape for reimbursement of minimally invasive spinal procedures.
High costs associated with capital equipment purchases and disposables.
Shortage of skilled professionals resulting from a lack of training.

---

Market Segmentation

---

The market is segmented based on various factors, including Condition, end user, and region.

Segmentation by Condition
Herniated Disc
Spinal Stenosis
Degenerative Disc Disease
Spinal Deformity
Spinal Fracture
Spinal Infection
Spinal Tumor

Segmentation by End User
Hospitals
Ambulatory Surgery Centers
Orthopedic Clinics

Segmentation by Region
North America – U.S. and Canada
Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
Asia-Pacific – Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific
Latin America – Brazil, Mexico, and Rest-of-Latin America
Middle East and Africa – South Africa, U.A.E, and Rest-of-Middle East and Africa

The degenerative disc disease segment dominated the global minimally invasive spine technologies market in 2021, with a value of $819 million, followed by the herniated disc segment at $662 million. Degenerative disc disease is a natural consequence of aging, where the intervertebral discs become less elastic, flexible, and shock-absorbing. It can also be caused by back injuries. Lumbar degenerative spine disease (DSD) is a common condition characterized by various clinical symptoms, including lower extremity discomfort, weakness, and low back pain (LBP) of varying severity, which significantly impacts quality of life. The incidence of spinal disorders, including degenerative spinal disorders and lower back pain, has been increasing globally. A study published in Sage Journals estimated that 266 million individuals worldwide had degenerative spinal disorders and LBP. As a result, there has been a growing adoption of minimally invasive spine surgery for the treatment of degenerative spinal diseases. Research suggests that in certain cases, minimally invasive spine surgery (MISS) is preferred over traditional open techniques.

The hospitals segment accounted for a significant share in the global minimally invasive spine technologies market, reaching $1,967 million in 2021, and is expected to reach $6,142 million by 2032, with a CAGR of 10.86% during the forecast period of 2022-2032. Hospitals are the primary purchasers of minimally invasive spine surgery products due to factors such as the increasing elderly population suffering from age-related spine disorders, rising prevalence of spinal disorders, preference for minimally invasive procedures, and technological advancements in minimally invasive spine technology. The demand for spine surgical robotic technologies from healthcare providers is also contributing to the growth in this segment. Private hospitals that can afford the cost-intensive robotic surgical systems and have the resources for surgeon training are leading the adoption of these minimally invasive spine procedures. However, there is a shift towards reducing healthcare costs by moving inpatient procedures to outpatient centers, impacting the purchasing patterns of hospitals.

North America held the largest market share of 50.74% in 2021, followed by Europe at 21.65%. The Asia Pacific region is expected to experience significant growth, with a CAGR of 12.66% during the forecast period of 2022-2032. North America and Europe have advanced healthcare systems and allocate substantial budgets to healthcare, making them key players in the global minimally invasive spine technologies market. The Asia Pacific, Latin America, and Middle East and Africa regions are anticipated to witness substantial growth due to increasing preference for minimally invasive surgeries, a rising geriatric population, and the demand to streamline surgical workflows.

North America is the dominant market for minimally invasive spine technologies and is projected to maintain its dominance in the future, growing at a CAGR of 10.95% during the forecast period of 2022-2032. The region boasts technologically advanced healthcare systems and a concentration of established manufacturers in the minimally invasive spine technologies market. The United States and Canada comprise the North America region, which serves as the hub of innovation in this field globally. Additionally, North America leads in the adoption of minimally invasive spine technologies.

---

Competitive Landscape

---

The selection of profiled companies is based on inputs collected from primary experts, as well as an analysis of company coverage, product portfolio, and market penetration.

Key companies profiled in this report include AMS Group, Alphatec Holdings, Inc., Aurora Spine, Inc., B. Braun SE, Boston Scientific Corporation, Globus Medical, Inc., Johnson & Johnson, Medtronic plc, NuVasive, Inc., ORTHOFIX MEDICAL INC., Precision Spine, Inc., Richard Wolf GmbH, Spineart, Spineology Inc., Stryker Corporation.

---

Recent Industry Developments

---

In June 2022, NuVasive, Inc. inaugurated its Singapore Experience Center in the Asia-Pacific region to facilitate the company’s growth and expand its global presence.

In April 2022, SeaSpine introduced the Reef TA (TLIF Articulating) Interbody System. This innovative system is designed to precisely deliver an interbody to the anterior part of the spinal disc space, aiming to improve sagittal alignment and provide enhanced support to the endplate. With a range of footprint and lordotic options, the Reef TA Interbody System offers surgeons flexibility in addressing specific anatomical requirements during surgical procedures.

In October 2022, Orthofix and SeaSpine merged on equal terms to establish a leading global company in the spine and orthopedics industry.

In July 2022, Medtronic plc obtained approval from the U.S. Food and Drug Administration (FDA) for the latest version of its UNiD Spine Analyzer, which incorporates a predictive model for degenerative spinal surgery.

In October 2022, Captiva Spine formed an exclusive strategic partnership with REMEX Medical for Spine Navigation and Robotics, aiming to expand their product portfolio.

---

Key Questions Answered

---

What are the primary market drivers, challenges, and opportunities in the global market for minimally invasive spine technologies?

What are the emerging trends in the global market for minimally invasive spine technologies?

What is the growth potential of the global market for minimally invasive spine technologies in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa?

What is the trend in patent filings within the global market for minimally invasive spine technologies?

What are some of the ongoing clinical trials in the global market for minimally invasive spine technologies?

How is the market segmented based on different conditions in the global market for minimally invasive spine technologies?

How has the COVID-19 pandemic impacted the global market for minimally invasive spine technologies?